Fresenius Reveals Denosumab Launch Details As It Settles US Litigation

German Firm Strikes Deal With Amgen Over Prolia/Xgeva Biosimilars

 
• By Dave Wallace
  
Fresenius Kabi has settled over denosumab in the US (Shutterstock)

More from Deals

More from Products